As of February 2026 Innovent Biologics has a market cap of A$25.44 Billion. This makes Innovent Biologics the world's 1272th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.